Table 1

Spirometer indices, AHR, and clinical markers during baseline and an exacerbation of asthma

Day 1Day 3Day 7Day 28
Baseline
(n=11)
(n=11)p*(n=11)p†(n=11)p‡(n=11)
Results expressed as median (quartiles).
*Wilcoxon test between baseline and day 1 data, †Wilcoxon test between baseline and day 3 data; ‡Wilcoxon test between baseline and day 7 data; §Friedman test for baseline, day 1, day 3, and day 7 data.
Asthma score0.21.750.021.50.1100.8700.00001
(child recorded)(0, 0.89)(0.75, 5)(0.25, 2.75)(0, 0.75)(0, 0)
Asthma score0.21.750.00810.0400.2100.00001
(parent recorded)(0, 0.88)(1.25, 4.5)(0.25, 3.75 )(0, 0.25)(0, 0)
Cough score0.663.50.00520.03710.7200.00001
(child recorded)(0.22, 1.44)(2,4)(1.75, 4)(0, 1)(0, 0)
Cough score0.7130.00320.0110.5100.00001
(parent recorded)(0, 1.44)(2, 4)(2, 4)(0, 2)(0, 0)
Child's QOL6.75.50.45.60.246.10.8870.19
(5, 7)(5.1, 6.3)(5.1, 6.1)(5.5, 6.3)(6.7, 7)
Parents' QOL65.60.165.50.815.80.886.40.71
(4.9, 6.7)(4.7, 6)(5.1, 5.9)(5.2, 6.6)(5.8, 7)
FEV1 % predicted8885.50.6685.50.21387.40.3387.40.25
(76, 100)(71, 92)(62, 92)(83, 98)(76, 90)
FVC % predicted94.590.70.0989.50.0995.40.7295.40.12
(85, 106)(83, 97)(75, 105)(89, 113)(88, 108)
FEV1 variability %7.414.50.064.60.288.50.074.60.18
(3, 11.3)(4.3, 23.7)(2.7, 17.1)(5.2, 27)(2.4, 9.9)
AHR positive, n (%)2 (18%)3 (30%)0.233 (30%)0.51 (10%)1.04 (40%)0.3